750 related articles for article (PubMed ID: 1373036)
41. Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits.
Holbrook M; Coker SJ
Br J Pharmacol; 1991 Aug; 103(4):1973-9. PubMed ID: 1655149
[TBL] [Abstract][Full Text] [Related]
42. Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
Grous M; Barnette M
Br J Pharmacol; 1994 Jan; 111(1):259-63. PubMed ID: 7516803
[TBL] [Abstract][Full Text] [Related]
43. Ca(2+)/calmodulin-dependent cyclic nucleotide phosphodiesterase in cGMP metabolism in rabbit parotid acinar cells.
Sairenji N; Satoh K; Sugiya H
Biomed Res; 2006 Feb; 27(1):37-44. PubMed ID: 16543664
[TBL] [Abstract][Full Text] [Related]
44. The isolation and characterization of cyclic nucleotide phosphodiesterases from Morris hepatoma 5123tc(h) and rat liver.
Turnbull JL; Hickie RA
Int J Biochem; 1984; 16(1):19-29. PubMed ID: 6321259
[TBL] [Abstract][Full Text] [Related]
45. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
[TBL] [Abstract][Full Text] [Related]
46. Cyclic 3':5'-nucleotide phosphodiesterase in human myometrium at the end of pregnancy: partial purification and characterization of the different soluble isoenzymes.
Leroy MJ; Pichard AL; Cabrol D; Ferre F
Gynecol Obstet Invest; 1985; 20(1):27-36. PubMed ID: 2995211
[TBL] [Abstract][Full Text] [Related]
47. Characterization of particulate cyclic nucleotide phosphodiesterases from bovine brain: purification of a distinct cGMP-stimulated isoenzyme.
Murashima S; Tanaka T; Hockman S; Manganiello V
Biochemistry; 1990 Jun; 29(22):5285-92. PubMed ID: 2166558
[TBL] [Abstract][Full Text] [Related]
48. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.
Torphy TJ; Stadel JM; Burman M; Cieslinski LB; McLaughlin MM; White JR; Livi GP
J Biol Chem; 1992 Jan; 267(3):1798-804. PubMed ID: 1309798
[TBL] [Abstract][Full Text] [Related]
49. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
50. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.
Souness JE; Scott LC
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267
[TBL] [Abstract][Full Text] [Related]
51. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.
Wilson M; Sullivan M; Brown N; Houslay MD
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009
[TBL] [Abstract][Full Text] [Related]
52. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle.
Weishaar RE; Kobylarz-Singer DC; Kaplan HR
J Mol Cell Cardiol; 1987 Oct; 19(10):1025-36. PubMed ID: 2830402
[TBL] [Abstract][Full Text] [Related]
53. Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei.
Lugnier C; Keravis T; Le Bec A; Pauvert O; Proteau S; Rousseau E
Biochim Biophys Acta; 1999 Nov; 1472(3):431-46. PubMed ID: 10564757
[TBL] [Abstract][Full Text] [Related]
54. Developmental differences in distribution of cyclic nucleotide phosphodiesterase isoforms in cardiomyocytes and the ventricular tissue from newborn and adult rats.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Cardiovasc Pharmacol; 1995 Nov; 26(5):742-50. PubMed ID: 8637189
[TBL] [Abstract][Full Text] [Related]
55. Changes in phosphodiesterase activity in the developing rat submandibular gland.
Tanaka S; Shimooka S; Shimomura H
Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
[TBL] [Abstract][Full Text] [Related]
56. cAMP analogs and selective inhibitors used to study low Km Mucor rouxii cAMP phosphodiesterase.
Tomes C; Moreno S
Int J Biochem; 1990; 22(9):1047-51. PubMed ID: 1704316
[TBL] [Abstract][Full Text] [Related]
57. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
58. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
Birnbaum RJ; Head JF
Biochem J; 1983 Dec; 215(3):627-36. PubMed ID: 6318728
[TBL] [Abstract][Full Text] [Related]
59. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
[TBL] [Abstract][Full Text] [Related]
60. Differential sensitivity to cardiotonic drugs of cyclic AMP phosphodiesterases isolated from canine ventricular and sinoatrial-enriched tissues.
Komas N; Lugnier C; Le Bec A; Serradeil-Le Gal C; Barthélémy G; Stoclet JC
J Cardiovasc Pharmacol; 1989 Aug; 14(2):213-20. PubMed ID: 2476593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
